AESTHETICFRANCHISE LTD

Company number 12646115 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

AESTHETICFRANCHISE LTD - Analysis Report

Company Number: 12646115

Analysis Date: 2025-07-20 17:19 UTC

Financial Health Assessment for AESTHETICFRANCHISE LTD (as at 30 June 2024)


1. Financial Health Score: D

Explanation:
The company currently shows distress signals in its financial health, primarily due to a dramatic reduction in net assets and negative working capital. While the business remains active and compliant with filings, its financial "vital signs" suggest significant liquidity and solvency challenges.


2. Key Vital Signs and Interpretation

Metric 2024 Value (£) 2023 Value (£) Interpretation
Net Assets 45 17,298 Critical drop (~99.7%) indicates severe erosion of shareholder equity. This is a major red flag.
Current Assets 34,639 44,750 Decreased liquidity available for short-term obligations; concerning but not catastrophic.
Cash at Bank 2,293 10,057 Sharp decline in cash reserves signals potential cash flow strain—“weak pulse” in cash flow.
Debtors 23,140 13,011 Increase in receivables can indicate sales growth or collection delays; here, collection risk.
Stocks 9,206 21,682 Decreased inventory may reflect attempts to reduce stock or lower demand; watch for turnover.
Current Liabilities 47,561 41,280 Increased short-term debts and obligations; “pressure on arteries” of the business finance.
Net Current Assets (Working Capital) -12,922 3,470 Negative working capital is a symptom of liquidity distress; liabilities exceed current assets.
Provisions for Liabilities (Deferred Tax) 833 875 Stable but adds to overall liabilities burden.
Shareholders' Funds 45 17,298 Mirrors net assets; equity nearly wiped out, indicating accumulated losses or write-downs.
Employee Count 0 1 Reduction to zero employees suggests downsizing or operational pause, affecting business health.

3. Diagnosis: What the Financial Data Reveals

AESTHETICFRANCHISE LTD’s financial "vital signs" resemble a patient experiencing acute financial distress, with symptoms including:

  • Severe depletion of net assets and shareholders' funds: The company’s equity has almost vanished by June 2024, indicating accumulated losses or significant write-downs. This is akin to a patient losing vital organ function.

  • Negative working capital: Current liabilities exceed current assets by £12,922, indicating that the company may struggle to meet its short-term obligations. This liquidity crunch signals a “weak heartbeat” in cash flow management.

  • Sharp decline in cash reserves: Cash at bank dropped from £10,057 to £2,293, suggesting cash burn or inability to generate sufficient liquid funds.

  • Rising debt and liabilities: Current liabilities increased, including a new "Other Loan" of £21,600 which was not present the previous year. This adds financial strain and interest obligations.

  • Decrease in stock levels: Could reflect attempts to free up cash or lower sales volume.

  • No employees reported during the year: This could indicate operational challenges or reliance on contractors or director involvement only, possibly reducing operational capacity.

Overall, the company exhibits symptoms of financial stress that, if untreated, could lead to insolvency risk. The business is still active but shows signs of struggling to maintain financial stability.


4. Recommendations: Steps to Improve Financial Wellness

Immediate Actions:

  • Liquidity Management:

    • Improve cash flow by accelerating debtor collections and negotiating extended payment terms with creditors.
    • Review inventory management to ensure stock is aligned with sales to avoid cash being tied up unnecessarily.
  • Financial Restructuring:

    • Assess the nature of the £21,600 loan: consider refinancing options or equity injections to reduce short-term pressures.
    • Explore support options such as director loans or shareholder funding to bolster working capital.
  • Cost Control:

    • Given the zero employee count, evaluate operational needs carefully to balance cost savings with business continuity.

Medium Term:

  • Profitability Improvement:

    • Analyze revenue streams and cost drivers to identify opportunities for margin improvement and sustainable profitability.
  • Financial Monitoring:

    • Implement regular financial health checks and cash flow forecasting to prevent future liquidity crises.
  • Stakeholder Communication:

    • Maintain transparent communication with creditors and investors regarding financial position and recovery plans to maintain confidence.

Strategic Review:

  • Consider reviewing business model and market positioning given the sector (specialist medical practice activities) to ensure alignment with demand and competitive environment.

Summary Analogy:

The company’s financial health is akin to a patient who has experienced a sudden drop in vital signs — the heart (cash flow) is weak, the blood pressure (working capital) is dangerously low, and the overall body reserves (net assets) are severely depleted. Immediate and decisive intervention is required to stabilise and restore financial vitality.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.